JBM (Healthcare) Ltd. (HK:2161) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
JBM (Healthcare) Ltd. reported a strong financial performance for the six months ending September 2024, with revenue climbing 22.1% to HK$399 million and profit from operations surging 41.7% to HK$121.6 million compared to the previous year. The company’s profit attributable to equity shareholders rose by 53.4%, amounting to HK$95.9 million. Additionally, JBM declared an interim dividend increase of 59.4%, highlighting its robust growth and commitment to shareholders.
For further insights into HK:2161 stock, check out TipRanks’ Stock Analysis page.